Donohoe J A, Andrus L, Bowen K M, Simeonovic C, Prowse S J, Lafferty K J
Transplantation. 1983 Jan;35(1):62-7. doi: 10.1097/00007890-198301000-00012.
Thyroid allografts (BALB/c) prepared for transplantation by cyclophosphamide pretreatment of the donor, followed by organ culture of donor tissues for 3 weeks in a gas phase of 95% O2-5% CO2 function in normal CBA recipient mice for greater than or equal to 350 days. Up to 100 days post-transplantation, the tissue can be rejected by challenge of the recipient with 10(5) BALB/c peritoneal cells. After prolonged residence in the recipient (greater than 100, less than or equal to 350 days), only a proportion of allografts are rejected when the recipient is challenged with 10(5) followed by 10(6) peritoneal cells of donor origin. Recipients of long-term allografts are partially tolerant of BALB/c tissues. They are hyporesponsive to in vivo challenge with BALB/c spleen cells. However, lymph node cells from these animals respond essentially normally to stimulation with BALB/c spleen cells in vitro. Tolerant recipients will accept a second uncultured BALB/c allograft after a transitory rejection crisis. This crisis is not observed in the primary allograft.
通过对供体进行环磷酰胺预处理,然后在95% O₂ - 5% CO₂ 的气相中对供体组织进行3周的器官培养来制备用于移植的甲状腺同种异体移植物(BALB/c),在正常CBA受体小鼠中可存活大于或等于350天。移植后长达100天,用10⁵ 个BALB/c腹腔细胞攻击受体可使组织被排斥。在受体中长期存活(大于100天,小于或等于350天)后,当用10⁵ 个随后10⁶ 个供体来源的腹腔细胞攻击受体时,只有一部分同种异体移植物会被排斥。长期同种异体移植物的受体对BALB/c组织有部分耐受性。它们对BALB/c脾细胞的体内攻击反应低下。然而,这些动物的淋巴结细胞在体外对BALB/c脾细胞的刺激基本正常反应。耐受的受体在短暂的排斥危机后将接受第二个未经培养的BALB/c同种异体移植物。在初次同种异体移植中未观察到这种危机。